ReviewJournal of molecular biology2017

Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer.

Simon Vyse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.